Abstract
Prevention of venous thromboembolism (VTE) in children should initially involve a risk assessment of which there are few within the literature. There are no specific national protocols for assessing VTE risk in children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The National Institute for Health and Care Excellence (NICE). Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE clinical guideline 92. Issued January 2010. http://www.nice.org.uk/guidance/cg92/resources/guidance-venous-thromboembolismreducing-the-risk-pdf. Accessed January 19, 2016.
Raffini L, Trimarchi T, Beliveau J, Davis D. Thromboprophylaxis in a paediatric hospital: a patient-safety and quality-improvement initiative. Pediatrics. 2011;127:e1326-e1332.
Jackson PC, Morgan JM. Perioperative thromboprophylaxis in children: development of a guideline for management. Pediatri Anesth. 2008;18:478-487.
Raffini L, Huang H-S, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124:1001-1008.
Journeycake JM, Manco-Johnson MJ. Thrombosis during infancy and childhood: what we know and what we don’t know. Hematol Oncol Clin North Am. 2004;18:1315-1338.
Male C, Chait P, Andrew M, Hanna K, Julian J, Mitchell L, PARKAA Investigators. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood. 2003;101:4273-4278.
Farinasso L, Bertorello N, Garbarini L, et al. Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study. Leukemia. 2007; 21:552-556.
Revel-Vilk S, Jacobovitch J, Tamary H, et al. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer. 2010;116:4197-4205.
Caruso V, Iacoviello L, Di Castelnuovo A, et al. Thrombotic complications in childhood acute lymphoblastic leukaemia. A meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216-2222.
Qureshi A, Mitchell C, Richards S, Vora A, Goulden N. Asparaginase-related venous thrombosis in UKALL 2003–re-exposure to asparaginase is feasible and safe. Br J Haematol. 2010;149:410-413.
Astwood E, Vora A. Personal practice: how we manage the risk of bleeding and thrombosis in children and young adults with acute lymphoblastic leukaemia. Brit Journ Haem. 2011;152:505-511.
Piovesan D, Attard C, Monagle P Ignjatovic V. Epidemiology of venous thrombosis in children with cancer. Thromb Haemost. 2014;111:1015-1021.
Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr. 1998;133:770-776.
Massicotte P, Mitchell L. Thromboprophylaxis of central venous lines in children with cancer: the first steps taken on the long road ahead. Acta Paediatr. 2006; 95:1049-1052.
van Ommen CH, Heijboer H, Buller H, Hirasing RA, Hijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr. 2001;139:676-681.
Braga AJ, Young AE. Preventing venous thrombosis in critically ill children: what is the right approach? Paediatr Anaesth. 2011;21:435-440.
Faustino EV, Hanson S, Spinella PC, et al. A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med. 2014;42:1232-1240.
Thompson AJ, McSwain SD, Webb SA, Stroud MA, Streck CJ. Thromboembolism prophylaxis in the pediatric trauma population. J Pediatr Surg. 2013;48:1413-1421.
Askegard-Giesmann JR, O’Brien SH, Wang W, Kenney BD. Increased use of enoxaparin in pediatric trauma patients. J Pediatr Surg. 2012;47:980-983.
O’Brien SH, Klima J, Gaines BA, Betz S, Zenati MS. Utilisation of low-molecular weight heparin in pediatric and adolescent trauma patients. J Trauma Nurs. 2012;19:117-121.
Greenwald LJ, Yost MT, Sponseller PD, Abdullah F, Ziegfeld SM, Ain MC. The role of clinically significant venous thromboembolism and thrombopropylaxis in pediatric patients with pelvic or femoral fractures. J Pediatr Orthop. 2012;32:357-361.
Hanson SJ, Punzalan RC, Arca MJ, et al. Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. J Trauma Acute Care Surg. 2012;72:1292-1297.
McCrindle BW, Manlhiot C, Cochrane A, et al. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. J Am Coll Cardiol. 2013;61:346-353.
Zitomersky NL, Levine AE, Atkinson BJ,et al. Risk factors, morbidity and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;57:343-347.
Kappelman MD, Horvath-Puho, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60:937-943.
Chalmers E, Ganesen V, Liesner R, Maroo S, Nokes T, Saunders D, Williams M. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol. 2011;154:196-207.
Mitchell L, Lambers M, Flege S, et al. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood. 2010;115:4999-5004.
Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous cathers. Cochrane database Syst Rev. 2001;CD002772.
Vegting IL, Tabbers MM, Benninga MA, et al. Prophylactic anticoagulation decreases catheterrelated thrombosis and occlusion in children with home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2012;36:456-462.
Amarigiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2010;CD001484.
Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2008;133:887–968.
Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration. The Lancet. 2013;382:516-524.
Baglin TP, Brush J, Strieff M. Guidelines on the use of Vena Cava filters. Br J Haematol. 2006;134:590-595.
Reed RA, Teitelbaum GP, Stanley P, Mazer MJ, Tonkin IL, Rollins NK. The use of Inferior Vena Cava filters in pediatric patients for pulmonary embolism prophylaxis. Cardiovasc Intervent Radiol. 1996;19:401-405.
Cahn MD, Rohrer MJ, Martella MB, Cutler BS. Long-term follow-up of Greenfield inferior vena cava filter placement in children. J Vasc Surg. 2001;34:820-825.
Monagle P, Chalmers E, Chan A, deVeber G, Kirkham F, Massicotte P, Michelson AD. Antithrombotic therapy in Neonates and Children: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th edition) Chest 2008;133(6-suppl):887S-968S
Haider EA, Choi Rosen J, Torres C, Valenti DA. Serial repositioning of a gunthe tulip retrievableinferior vena cava filter in a pediatric patient. Paediatr Radiol. 2005;35:1135-1138.
Brandao LR, Shah N, Shah PS. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children. Cochrane Database Syst Rev. 2014;3:CD005982.
Meister B, Kropshofer G, Klein-Franke A, Strasak AM, Hager J, Streif W. Comparison of low molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50:298-303.
Mitchell L, Andrew M, Hanna K, et al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb Haemost. 2003;90:235-244.
Abbott, LS, Deevska M, Fernandez CV, et al. The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase. Blood. 2009;114:5146-5151
Raffini L, Thornburg C. Testing children for inherited thrombophilia: more questions than answers. Br J Haematol. 2009;147:277-288.
Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11:56-70.
Sabharwal S, Passannante MR. Venous thromboembolism in children: preliminary results of a survey of POSNA members. J Pediatr Orthop. 2013;33:852-856.
Ruud EL, Holmstrom H, De Lange C, Hogstad EM, Wesenberg F. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies-a randomized, controlled study. Acta Paediatr. 2006;95:1053-1059.
Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, et al. PROTEKT Study Group. An open- label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thrombosis Research. 2003;109:101-108.
Schoot RA, Kremer LC, van de Wetering MD, van Ommen CH. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. Cochrane Database Syst Rev. 2013;9:CD009160.
Vidal E, Sharathkumar A, Glover J, Faustino EV. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis. J Thromb Haemost. 2014;12:1096-1109.
Lyle CA, Sidonio RF, Goldenberg NA. New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants. Curr Opin Pediatr. 2015;27:18-25.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Nokes, T. (2016). Venous thromboprophylaxis in children. In: Perry, D., Warwick, D. (eds) Handbook of Thromboprophylaxis. Adis, Cham. https://doi.org/10.1007/978-3-319-21148-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-21148-0_9
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-21147-3
Online ISBN: 978-3-319-21148-0
eBook Packages: MedicineMedicine (R0)